![]() |
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Staphylococcus aureus recently shows resistance to many Beta lactam antibiotics and Carbapenems. This study is focused on the incidence of MRSA in NICUs. Using Gram staining, blood culture and antibiotic sensitivity tests, MRSA can be identified. Septicemia is diagnosed not only by the isolation of the organism in blood culture. It should be correlated with total count, CRP like lab investigations and clinical features. Sometimes repeated blood culture is needed to confirm the diagnosis and to assess the prognosis. Methicillin resistant Coagulase negative Staphylococcus aureus and Methicillin resistant Staphylococcus aureus are more challenges in management of neonatal septicemia. MRSA shows resistant to many of the drugs including Gentamycin, Amikacin and Piperacillin+Tazobactam. It is sensitive only to Vancomycin, Linezolid antibiotics. Early diagnosis and prompt treatment based on the Antibiotic sensitivity test results will prevent the spread of drug resistant strain and also decrease the morbidity and mortality in NICUs. Implementation of aggressive infection control measures and appropriate hand hygine practices are enforce for health care workers and proper isolation of neonates in NICU and surveillance of nasal carrier of health care persons and treatment with nasal mupirocin 3 times per day for 5 consective days are very important in preventing mrsa out breaks and neonatel septisemia.
![]() |
![]() |
![]() |
![]() |
![]() |